Abstracts

Comparison of Combination ART Regimens for Viral Suppression in SIV-Infected Rhesus Macaques

Background: Nonhuman primate (NHP) models of human HIV infection, including the most commonly used model involving SIV-infected Indian rhesus macaques, represent an important component of the HIV cure research agenda. Feasible, sustainable combination antiretroviral treatment (cART) regimens to achieve clinically relevant levels of suppression (SIV plasma RNA < 30 copies/ml) are an essential element to…

Pre-ART HIV-1 RNA as well as On-treatment CD8 Count and CD4/CD8 ratio Predict Residual Viremia on ART

Background: Prior studies have identified pre-ART plasma HIV-1 RNA level as the strongest predictor of residual viremia on ART but analyses have had limited power to identify other associations. We examined pre-therapy and on-treatment predictors of residual viremia in a large, well-characterized ACTG cohort. Methodology: Plasma samples obtained 192 and 208 weeks after ART initiation…

CRM-1 A CRITICAL REGULATOR OF HIV REPLICATION IN A QUEST TOWARDS A SMALL ANIMAL MODEL FOR HIV

Background: Combination anti-retroviral therapy has markedly improved the prognosis of individuals living with HIV, yet treatment is not curative, and is often limited by major side effects, emerging viral resistance, drug interactions, and high costs. Furthermore, pathogenesis studies, vaccine development and drug testing are severely hampered by lack of small animal models for HIV infection.…

Analyses of the Sequence-Function Relationships Among HIV-1 Vpr SIVagmVpr and SIVmacVpx

Background: Lentiviral accessory proteins are known for their ability to counteract host immune responses. Despite the sequence similarity shared by Vpr and Vpx, and the fact that both proteins hijack the cellular CRL4 E3 ligase via DCAF1 interaction, they have very different functions. Vpx causes degradation of cellular SAMHD1, making viral replication in myeloid cells…

Elevated Expression of Anti-HIV-1 Restriction Factors in Effector Memory CD4+ T cells in vivo*

Background: Recent observations suggest that there may be less viral outgrowth from effector memory than central memory CD4+ T cells from ART-suppressed individuals, despite similar levels of HIV-1 DNA in these cellular subsets. This may be driven by cell-intrinsic factors suppressing viral production, and/or the disproportionate presence of replication-incompetent HIV-1 variants in effector memory cells.…

TRIM5alpha Determinants for the Activation of Innate Immunity

Background: Specific recognition of incoming viral capsids by the anti-retroviral factor TRIM5α disrupts progression of the virus life cycle and also triggers the induction of an antiviral state involving the activation of transcription factors NF-κB and AP-1. Additionally, TRIM5α promotes the formation of K63-linked ubiquitin chains which are thought to be important for innate immunity…

HIV-1 Vpu Antagonizes Macaque and Chimpanzee BST-2 Through Cytoplasmic Domain Interactions

Background: The HIV-1 Vpu protein enhances the release of viral particles from infected cells by interfering with host factor BST-2/tetherin, which tethers nascent virions to the cell surface and inhibits virus release. Previous work demonstrated that HIV-1 NL4-3 Vpu can target human BST-2 (huBST-2) but not monkey BST-2 (moBST-2), suggesting a species-specific activity. However, we…